- Home
- CPHC vs CRVO Comparison
CPHC vs CRVO Comparison
Compare CPHC & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPHC
- CRVO
- Stock Information
- Founded
- CPHC 1994
- CRVO 2001
- Country
- CPHC United States
- CRVO United States
- Employees
- CPHC N/A
- CRVO N/A
- Industry
- CPHC Services-Misc. Amusement & Recreation
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- CPHC Consumer Discretionary
- CRVO Health Care
- Exchange
- CPHC Nasdaq
- CRVO Nasdaq
- Market Cap
- CPHC 83.3M
- CRVO 71.1M
- IPO Year
- CPHC 1994
- CRVO N/A
- Fundamental
- Price
- CPHC $15.14
- CRVO $9.09
- Analyst Decision
- CPHC
- CRVO Strong Buy
- Analyst Count
- CPHC 0
- CRVO 6
- Target Price
- CPHC N/A
- CRVO $21.50
- AVG Volume (30 Days)
- CPHC 1.9K
- CRVO 77.3K
- Earning Date
- CPHC 11-06-2025
- CRVO 11-10-2025
- Dividend Yield
- CPHC 1.83%
- CRVO N/A
- EPS Growth
- CPHC N/A
- CRVO N/A
- EPS
- CPHC N/A
- CRVO N/A
- Revenue
- CPHC $59,099,604.00
- CRVO $6,159,786.00
- Revenue This Year
- CPHC N/A
- CRVO N/A
- Revenue Next Year
- CPHC N/A
- CRVO N/A
- P/E Ratio
- CPHC N/A
- CRVO N/A
- Revenue Growth
- CPHC N/A
- CRVO N/A
- 52 Week Low
- CPHC $15.11
- CRVO $1.80
- 52 Week High
- CPHC $22.93
- CRVO $16.94
- Technical
- Relative Strength Index (RSI)
- CPHC 36.64
- CRVO 70.21
- Support Level
- CPHC $15.26
- CRVO $7.51
- Resistance Level
- CPHC $15.99
- CRVO $9.45
- Average True Range (ATR)
- CPHC 0.14
- CRVO 0.60
- MACD
- CPHC -0.03
- CRVO 0.26
- Stochastic Oscillator
- CPHC 4.02
- CRVO 91.86
About CPHC Canterbury Park Holding Corporation 'New'
Canterbury Park Holding Corp is in the business of pari-mutuel wagering on horse races and unbanked card games at its canterbury park racetrack and card casino facility in Minnesota. The company has four operating segments. The horse racing segment represents pari-mutuel wagering operations on simulcast and lives horse races; the Casino segment represents unbanked card operations; the food and beverage segment includes concessions, catering, and events services provided at the Racetrack; and the development segment represents its real estate development operations. The firm generates a majority of its revenue from the Casino segment.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.